Total Payments
$2.0M
2024 Payments
$573,397
Companies
25
Transactions
2,019
Payment Breakdown by Category
Other$1.4M (71.1%)
Consulting$377,132 (18.6%)
Travel$157,573 (7.8%)
Food & Beverage$49,576 (2.4%)
Education$116.04 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.4M | 517 | 70.4% |
| Consulting Fee | $377,132 | 97 | 18.6% |
| Travel and Lodging | $157,573 | 672 | 7.8% |
| Food and Beverage | $49,576 | 719 | 2.4% |
| Honoraria | $15,191 | 10 | 0.8% |
| Education | $116.04 | 4 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $477,333 | 459 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $281,900 | 255 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $218,686 | 210 | $0 (2024) |
| ITI, Inc. | $211,977 | 209 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $186,912 | 233 | $0 (2022) |
| ACADIA Pharmaceuticals Inc | $150,062 | 132 | $0 (2024) |
| ABBVIE INC. | $124,785 | 145 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $95,521 | 98 | $0 (2024) |
| Axsome Therapeutics, Inc. | $77,271 | 69 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $69,480 | 53 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $573,397 | 534 | Teva Pharmaceuticals USA, Inc. ($114,076) |
| 2023 | $480,620 | 450 | Alkermes, Inc. ($153,010) |
| 2022 | $240,529 | 251 | ITI, Inc. ($78,899) |
| 2021 | $89,857 | 87 | ITI, Inc. ($40,145) |
| 2020 | $58,582 | 54 | Alkermes, Inc. ($24,332) |
| 2019 | $232,344 | 263 | Sunovion Pharmaceuticals Inc. ($88,324) |
| 2018 | $111,301 | 111 | Alkermes, Inc. ($52,046) |
| 2017 | $237,301 | 269 | Sunovion Pharmaceuticals Inc. ($88,056) |
All Payment Transactions
2,019 individual payment records from CMS Open Payments — Page 1 of 81
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,150.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/23/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Consulting Fee | Cash or cash equivalent | $1,230.00 | General |
| Category: Neurology | ||||||
| 12/20/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,489.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/19/2024 | ABBVIE INC. | ELAHERE (Drug) | Consulting Fee | Cash or cash equivalent | $18,160.00 | General |
| Category: ONCOLOGY | ||||||
| 12/19/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Consulting Fee | Cash or cash equivalent | $1,875.00 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,222.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $65.00 | General |
| 12/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,250.00 | General |
| Category: Neuropsychiatry | ||||||
| 12/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $126.72 | General |
| Category: Neuropsychiatry | ||||||
| 12/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $21.44 | General |
| Category: Neuropsychiatry | ||||||
| 12/13/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Consulting Fee | Cash or cash equivalent | $1,250.00 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Travel and Lodging | Cash or cash equivalent | $280.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,148.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/05/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Consulting Fee | Cash or cash equivalent | $1,875.00 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $121.83 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Travel and Lodging | Cash or cash equivalent | $85.12 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $124.70 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $76.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $386.68 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $290.77 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $187.96 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $85.97 | General |
| Category: NEUROSCIENCE | ||||||
About Dr. Jonathan Meyer, M.D
Dr. Jonathan Meyer, M.D is a Psychiatry healthcare provider based in San Diego, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003832809.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Meyer, M.D has received a total of $2.0M in payments from pharmaceutical and medical device companies, with $573,397 received in 2024. These payments were reported across 2,019 transactions from 25 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1.4M).
Ad
Practice Information
- Specialty Psychiatry
- Location San Diego, CA
- Active Since 07/14/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1003832809
Products in Payments
- CAPLYTA (Drug) $307,498
- INGREZZA (Drug) $273,198
- ARISTADA (Drug) $205,919
- LATUDA (Drug) $182,056
- LYBALVI (Drug) $176,462
- UZEDY (Drug) $146,830
- NUPLAZID (Drug) $146,312
- VRAYLAR (Drug) $128,879
- Auvelity (Drug) $77,271
- Aristada 441 mg (Drug) $75,163
- REXULTI (Drug) $44,584
- COBENFY (Drug) $29,896
- Austedo XR (Drug) $23,313
- BELSOMRA (Drug) $22,534
- ELAHERE (Drug) $18,160
- SECUADO (Drug) $13,276
- ABILIFY MAINTENA (Drug) $10,891
- AUSTEDO (Drug) $9,442
- SD809-TD (Drug) $6,335
- SPRAVATO (Drug) $5,188
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in San Diego
Dr. Sanjai Rao, M.d, M.D
Psychiatry — Payments: $633,149
Psychiatry $633,149
Dr. Murray Stein, M.d., M.p.h, M.D., M.P.H
Psychiatry — Payments: $115,110
Psychiatry $115,110
Dr. Mukesh Sanghadia, M.d., Mrcpsych(Uk), M.D., MRCPSYCH(UK)
Psychiatry — Payments: $82,626
Psychiatry $82,626
Dr. Neil Richtand, M.d, M.D
Psychiatry — Payments: $76,458
Psychiatry $76,458
Clark Smith, Md, MD
Psychiatry — Payments: $72,261
Psychiatry $72,261
Dr. Vishaal Mehra, Md, MD
Psychiatry — Payments: $56,945
Psychiatry $56,945